📣 VC round data is live. Check it out!

Apollo Hospitals Valuation Multiples

Discover revenue and EBITDA valuation multiples for Apollo Hospitals and similar public comparables like Aier EYE Hospital Group, DaVita, Encompass Health, Max Healthcare Institute and more.

Apollo Hospitals Overview

About Apollo Hospitals

Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.


Founded

1979

HQ

India

Employees

18.6K

Financials (LTM)

Revenue: $3B
EBITDA: $402M

EV

$13B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Apollo Hospitals Financials

Apollo Hospitals reported last 12-month revenue of $3B and EBITDA of $402M.

In the same LTM period, Apollo Hospitals generated $1B in gross profit, $402M in EBITDA, and $211M in net income.

Revenue (LTM)


Apollo Hospitals P&L

In the most recent fiscal year, Apollo Hospitals reported revenue of $3B and EBITDA of $416M.

Apollo Hospitals is profitable as of last fiscal year, with gross margin of 48%, EBITDA margin of 16%, and net margin of 8%.

See analyst estimates for Apollo Hospitals
LTMLast FY202320242025202620272028
Revenue$3B$3B$2B$2B$3B
Gross Profit$1B$1B$915M$1B$1B
Gross Margin48%48%48%48%48%
EBITDA$402M$416M$242M$315M$396M
EBITDA Margin15%16%13%14%16%
EBIT Margin12%11%9%10%11%
Net Profit$211M$203M$92M$137M$190M
Net Margin8%8%5%6%7%
Net Debt—$506M———

Financial data powered by Morningstar, Inc.

Apollo Hospitals Stock Performance

Apollo Hospitals has current market cap of $13B, and enterprise value of $13B.

Market Cap Evolution


Apollo Hospitals' stock price is $87.36.

Apollo Hospitals share price increased by 8.6% in the last 30 days, and by 17.3% in the last year.

Apollo Hospitals has an EPS (earnings per share) of $1.41.

See more trading valuation data for Apollo Hospitals
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13B$13B0.0%8.6%4.3%17.3%$1.41

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Apollo Hospitals Valuation Multiples

Apollo Hospitals trades at 4.9x EV/Revenue multiple, and 32.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Apollo Hospitals

EV / Revenue (LTM)


Apollo Hospitals Financial Valuation Multiples

As of May 25, 2026, Apollo Hospitals has market cap of $13B and EV of $13B.

Apollo Hospitals has a P/E ratio of 59.6x.

LTMLast FY202320242025202620272028
EV/Revenue4.9x5.0x6.9x6.0x5.2x
EV/EBITDA32.8x31.7x54.5x41.9x33.3x
EV/EBIT42.6x43.7x76.9x59.2x46.1x
EV/Gross Profit10.2x10.4x14.4x12.7x10.8x
P/E59.6x61.9x136.8x91.9x66.1x
EV/FCF185.7x141.4x194.6x246.1x162.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Apollo Hospitals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Apollo Hospitals Margins & Growth Rates

Apollo Hospitals grew revenue by 19% and EBITDA by 14% in the last fiscal year.

In the most recent fiscal year, Apollo Hospitals reported gross margin of 48%, EBITDA margin of 16%, and net margin of 8%.

See estimated margins and future growth rates for Apollo Hospitals

Apollo Hospitals Margins

Last FY202420252026202720282029
Gross Margin48%48%48%49%
EBITDA Margin16%14%16%15%
EBIT Margin11%10%11%12%
Net Margin8%6%7%8%
FCF Margin4%2%3%6%

Apollo Hospitals Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth19%14%16%18%
Gross Profit Growth20%14%17%20%
EBITDA Growth14%30%26%16%
EBIT Growth24%30%28%25%
Net Profit Growth26%49%39%28%
FCF Growth122%(21%)51%121%

Data powered by FactSet, Inc. and Morningstar, Inc.

Apollo Hospitals Operational KPIs

Apollo Hospitals' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Apollo Hospitals' Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Apollo Hospitals' Rule of X is 61% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Apollo Hospitals
LTMLast FY202320242025202620272028
Rule of 4035%34%———
Bessemer Rule of X64%61%———
Revenue per Employee—$0.1M———
Opex per Employee—$0.1M———
S&M Expenses to Revenue——4%3%2%
G&A Expenses to Revenue——10%10%9%
Opex to Revenue—37%39%37%37%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Apollo Hospitals Competitors

Apollo Hospitals competitors include Aier EYE Hospital Group, DaVita, Encompass Health, Max Healthcare Institute, Rede D'Or São Luiz, Tenet Healthcare, Mayapada Hospital, Universal Health Services, Bangkok Dusit Medical Services and Fortis Healthcare.

Most Apollo Hospitals public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aier EYE Hospital Group3.9x3.7x13.2x12.8x
DaVita1.9x1.8x9.0x8.9x
Encompass Health2.2x2.1x9.3x10.0x
Max Healthcare Institute12.0x11.3x39.8x38.5x
Rede D'Or São Luiz1.5x1.5x7.1x8.1x
Tenet Healthcare1.2x1.2x5.5x5.5x
Mayapada Hospital67.3x—700.0x—
Universal Health Services0.8x0.8x5.3x5.5x

This data is available for Pro users. Sign up to see all Apollo Hospitals competitors and their valuation data.

Start Free Trial

Apollo Hospitals Funding History

Before going public, Apollo Hospitals raised $170M in total equity funding, across 1 round.


Apollo Hospitals Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Aug-25Secondary - publicAbu Dhabi Investment Authority; Axis Mutual Fund; BNP Paribas; Copthall Mauritius Investment; Fidelity; Ghisallo Master Fund; Goldman Sachs; Invesco Mutual Fund; T. Rowe Price; Morgan Stanley; Morningstar; Société Générale$170M——

Apollo Hospitals M&A Activity

Apollo Hospitals has acquired 3 companies to date.

Last acquisition by Apollo Hospitals was on October 5th 2022. Apollo Hospitals acquired AyurVAID for $3M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Apollo Hospitals

AyurVAID
Assam Hospitals
Raj Shree Hospital
Description
AyurVAID is India's largest chain of Ayurveda hospitals treating chronic conditions like diabetes and arthritis for low-income communities.
Assam Hospitals manages a network of multi-specialty facilities across Assam, India, providing comprehensive healthcare services including surgery, diagnostics, and emergency care.
Indore-based Raj Shree Hospital functions as a super specialty corporate facility delivering cardiology, neurology, orthopedics, gynecology, gastroenterology, and intensive care alongside emergency response, laboratory testing, radiology imaging, pharmacy services, ambulance transport, and blood bank operations. The hospital supports advanced procedures in joint replacement, spine surgery, laparoscopic operations, MRI diagnostics, CT scans, and rehabilitation programs plus preventive screenings for diabetes, obesity, and joint issues.
HQ CountryIndiaIndiaIndia
HQ City
Bangalore
Guwahati
Gorakhpur
Deal Date5 Oct 20222 Jun 201525 Jun 2014
Valuation$3M$18M$6M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Apollo Hospitals acquisitions and their M&A valuation multiples.

Start Free Trial

Apollo Hospitals Investment Activity

Apollo Hospitals has invested in 4 companies to date.

Latest investment by Apollo Hospitals was on November 29th 2021. Apollo Hospitals invested in ZenOncoIO in their $1M Seed round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Apollo Hospitals

ZenOncoIO
Kindly His
Impact Guru
Medics International Lifesciences Ltd.
Description
ZenOncoIO is a Mumbai-based oncology network delivering integrated cancer care across 50 hospitals in India. Services encompass robotic surgery, precision chemotherapy, and proton therapy tailored by genomic profiling. The platform connects patients to specialists via telemedicine and AI-driven treatment planning. Launched in 2021, ZenOncoIO partners with Tata Memorial Hospital for rural outreach programs serving over 10,000 patients annually.
—
Impact Guru is a Mumbai-headquartered fintech platform enabling equity, reward, and donation-based crowdfunding for startups, nonprofits, and social enterprises across Asia. The company operates campaigns from offices in New Delhi, Singapore, Hong Kong, Jakarta, Kuala Lumpur, and San Francisco. Incubated at Harvard Innovation Lab in 2014, Impact Guru has raised $100 million for 5,000 projects including healthcare and disaster relief.
Medics International Lifesciences Ltd. is a superspecialty hospital in Kerala, India, delivering quaternary care through advanced infrastructure and equipment. Located in Perinthalmanna, it operates multiple facilities emphasizing ethical practices in cardiology, neurology, orthopedics, and oncology. The institution serves patients across northern Kerala with comprehensive diagnostic and surgical services.
HQ CountryIndiaIndiaIndiaIndia
HQ City
Bangalore
Bangalore
Mumbai
Lucknow
Deal Date29 Nov 202125 Mar 202118 Dec 20185 Jul 2018
RoundSeedSeedSeries AStrategic investment
Raised$1M$1M$2M$13M
InvestorsApollo Hospitals; Arvind Kumar; Better Capital; Enzia Ventures; Titan Capital100Unicorns; Apollo Hospitals; Inflection Point Ventures; LVX Ventures; Venture CatalystsApollo Hospitals; Shorooq Partners; Venture CatalystsApollo Hospitals
Valuationundisclosedundisclosedundisclosed$26M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Apollo Hospitals investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Apollo Hospitals

When was Apollo Hospitals founded?Apollo Hospitals was founded in 1979.
Where is Apollo Hospitals headquartered?Apollo Hospitals is headquartered in India.
How many employees does Apollo Hospitals have?As of today, Apollo Hospitals has over 18K employees.
Is Apollo Hospitals publicly listed?Yes, Apollo Hospitals is a public company listed on National Stock Exchange of India.
What is the stock symbol of Apollo Hospitals?Apollo Hospitals trades under APOLLOHOSP ticker.
When did Apollo Hospitals go public?Apollo Hospitals went public in 1996.
Who are competitors of Apollo Hospitals?Apollo Hospitals main competitors include Aier EYE Hospital Group, DaVita, Encompass Health, Max Healthcare Institute, Rede D'Or São Luiz, Tenet Healthcare, Mayapada Hospital, Universal Health Services, Bangkok Dusit Medical Services, Fortis Healthcare.
What is the current market cap of Apollo Hospitals?Apollo Hospitals' current market cap is $13B.
What is the current revenue of Apollo Hospitals?Apollo Hospitals' last 12 months revenue is $3B.
What is the current revenue growth of Apollo Hospitals?Apollo Hospitals revenue growth (NTM/LTM) is 20%.
What is the current EV/Revenue multiple of Apollo Hospitals?Current revenue multiple of Apollo Hospitals is 4.9x.
Is Apollo Hospitals profitable?Yes, Apollo Hospitals is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Apollo Hospitals?Apollo Hospitals' last 12 months EBITDA is $402M.
What is Apollo Hospitals' EBITDA margin?Apollo Hospitals' last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Apollo Hospitals?Current EBITDA multiple of Apollo Hospitals is 32.8x.
What is the current FCF of Apollo Hospitals?Apollo Hospitals' last 12 months FCF is $71M.
What is Apollo Hospitals' FCF margin?Apollo Hospitals' last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Apollo Hospitals?Current FCF multiple of Apollo Hospitals is 185.7x.
How many companies Apollo Hospitals has acquired to date?As of May 2026, Apollo Hospitals has acquired 3 companies.
What was the largest acquisition by Apollo Hospitals?$18M acquisition of Assam Hospitals on 2nd June 2015 was the largest M&A Apollo Hospitals has done to date.
What companies Apollo Hospitals acquired?Apollo Hospitals acquired Assam Hospitals, Raj Shree Hospital, and AyurVAID.
In how many companies Apollo Hospitals has invested to date?As of May 2026, Apollo Hospitals has invested in 4 companies.
What was the last Apollo Hospitals investment?On 29th November 2021 Apollo Hospitals invested in ZenOncoIO, participating in a $1M Seed round, alongside Arvind Kumar, Better Capital, Enzia Ventures, and Titan Capital.
In what companies Apollo Hospitals invested in?Apollo Hospitals invested in Medics International Lifesciences Ltd., Impact Guru, ZenOncoIO, and Kindly His.

See public comps similar to Apollo Hospitals

Lists including Apollo Hospitals

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial